Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil.

The trichothecene mycotoxin deoxynivalenol (DON) induces IgA hyperelevation and mesangial IgA deposition in mice that mimics the early stages of human IgA nephropathy (IgAN). Among potential mediators of this disease, interleukin-6 (IL-6) is likely to play a particularly critical role in IgA elevation and disease exacerbation. Based on previous findings that dietary fish oil (FO) suppresses DON-induced IgAN, we hypothesized that FO inhibits the induction of IL-6 expression by this mycotoxin in vivo and in vitro. Mice were fed modified AIN 93G diet amended with 7% corn oil (CO) or with 1% corn oil plus 6% menhaden fish oil (FO) for up to 8 weeks and then exposed acutely to DON by oral gavage. DON-induced plasma IL-6 and splenic mRNA elevation in FO-fed mice were significantly suppressed after 8 weeks when compared to the CO-fed group. The effects of FO on phosphorylation of mitogen-activated protein kinases (MAPKs), critical upstream transducers of IL-6 up-regulation, were also assessed. DON-induced phosphorylation of extracellular signal regulated protein kinases 1 and 2 (ERK1/2) and c-Jun N-terminal kinases 1 and 2 (JNK1/2) was significantly suppressed in spleens of mice fed with FO, whereas p38 was not. Splenic COX-2 mRNA expression, which has been previously shown to enhance DON-induced IL-6, was also significantly decreased by FO, whereas plasma levels of the COX-2 metabolite, prostaglandin E2, were not affected. To confirm in vivo findings, the effects of pretreatment with the two primary n-3 PUFAs in FO, eicosapentaenoic acid (20:5[n-3]; EPA) and docosahexaenoic acid, (22:6[n-3]; DHA), on DON-induced IL-6 expression were assessed in LPS-treated RAW 264.7 macrophage cells. Consistent with the in vivo findings, both EPA and DHA significantly suppressed IL-6 superinduction by DON, as well as impaired DON-induced ERK1/2 and JNK1/2 phosphorylation. In contrast, the n-6 PUFA arachidonic acid (20:4[n-3]) had markedly less effects on these MAPKs. Taken together, the capacity of FO and its component n-3 PUFAs to suppress IL-6 expression as well as ERK 1/2 and JNK 1/2 activation might explain, in part, the reported suppressive effects of these lipids on DON-induced IgA nephropathy.

[1]  J. Pestka,et al.  Quantitative assessment of mesangial immunoglobulin A (IgA) accumulation, elevated circulating IgA immune complexes, and hematuria during vomitoxin-induced IgA nephropathy. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[2]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[3]  M. McCarty.  Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. , 1999, Medical hypotheses.

[4]  J. Heuvel,et al.  Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARγ-dependent mechanism , 2002 .

[5]  T. Hamazaki,et al.  REDUCTION OF DELAYED‐TYPE HYPERSENSITIVITY BY THE INJECTION OF n‐3 POLYUNSATURATED FATTY ACIDS IN MICE , 1992, Transplantation.

[6]  L. Harbige,et al.  Dietary fatty acid modulation of mucosally-induced tolerogenic immune responses , 2001, Proceedings of the Nutrition Society.

[7]  T. Libermann,et al.  Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide , 1994, Molecular and cellular biology.

[8]  C. Y. Lin,et al.  In vitro effects of interleukins on human mesangial cells: Implications for glomerulonephritis , 1995, The Journal of pathology.

[9]  J. Pestka,et al.  Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course. , 1997, Toxicology and applied pharmacology.

[10]  Z. Islam,et al.  Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  T. Larson,et al.  The Long-Term Outcome of Patients with IgA Nephropathy Treated with Fish Oil in a Controlled Trial , 1999 .

[12]  S. Rhee,et al.  Activation of Phospholipase C-γ by the Concerted Action of Tau Proteins and Arachidonic Acid* , 1996, Journal of Biological Chemistry.

[13]  T. Larson,et al.  A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. , 2001, Journal of the American Society of Nephrology : JASN.

[14]  C. Stewart,et al.  Quantitative RT-PCR for measuring gene expression. , 1995, BioTechniques.

[15]  J. Pestka,et al.  EFFECTS OF VOMITOXIN (DEOXYNIVALENOL) ON THE BINDING OF TRANSCRIPTION FACTORS AP-1, NF-κB, AND NF-IL6 IN RAW 264.7 MACROPHAGE CELLS , 2002, Journal of Toxicology and Environmental Health, Part A.

[16]  J. Pestka,et al.  Dysregulation of IgA production and IgA nephropathy induced by the trichothecene vomitoxin. , 1989, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  E. Shacter,et al.  Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Pestka,et al.  Dietary fish oil suppresses experimental immunoglobulin a nephropathy in mice. , 2002, The Journal of nutrition.

[19]  J. Pestka,et al.  Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. , 1997, Toxicology.

[20]  G. D'Amico,et al.  Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  R. Roberts.  Evidence for Cross Talk between PPARα and p38 MAP Kinase , 2002 .

[22]  M. Abbey,et al.  Effects of n-3 fatty acids on growth and survival of J774 macrophages. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.

[23]  J. Pestka,et al.  Toxicology of deoxynivalenol (vomitoxin). , 1996, Journal of toxicology and environmental health.

[24]  W. Koenig,et al.  Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.

[25]  K. Clark,et al.  Evidence That the Bradykinin-induced Activation of Phospholipase D and of the Mitogen-activated Protein Kinase Cascade Involve Different Protein Kinase C Isoforms (*) , 1995, The Journal of Biological Chemistry.

[26]  J. Pringle,et al.  Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA. , 1998, BioTechniques.

[27]  B. Chandrasekar,et al.  Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. , 1994, Biochemical and biophysical research communications.

[28]  D. Zeeuw,et al.  ABSENCE OF CROSS-REACTIVITY BETWEEN CAPTOPRIL AND ENALAPRIL , 1984, The Lancet.

[29]  D. Ergas,et al.  n-3 fatty acids and the immune system in autoimmunity. , 2002, The Israel Medical Association journal : IMAJ.

[30]  S. Tafuri,et al.  Regulation of Peroxisome Proliferator-activated Receptor γ Activity by Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[31]  G. Fernandes,et al.  The Importance of Omega-3 Fatty Acids in the Attenuation of Immune-Mediated Diseases , 2001, Journal of Clinical Immunology.

[32]  A. Hichami,et al.  Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells , 2001, Lipids.

[33]  W. Fiers,et al.  The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.

[34]  F. Amano,et al.  Suppression of prostaglandin synthesis by arachidonic acid or eicosapentaenoic acid in a macrophage-like cell line, RAW 264.7, treated with LPS. , 1999, Biological & pharmaceutical bulletin.

[35]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[36]  W. Bennett,et al.  Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial. , 1989, Clinical nephrology.

[37]  R. Roberts.  FORUM Evidence for Cross Talk between PPAR and p38 MAP Kinase , 2002 .

[38]  E. Coligan.  Current protocols in immunology , 1991 .

[39]  E. Vellenga,et al.  Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. , 1999, Journal of immunology.

[40]  N. Yorioka,et al.  Interleukin-6 Localization and the Prognosis of IgA Nephropathy , 1999, Nephron.

[41]  A. Chu,et al.  Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide. , 2000, JPEN. Journal of parenteral and enteral nutrition.

[42]  T. Utsumi,et al.  Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. , 2001, Biochemical pharmacology.

[43]  H. Lippert,et al.  Immunomodulation by perioperative administration of n-3 fatty acids , 2002, British Journal of Nutrition.

[44]  Klaus Resch,et al.  The p38 MAP kinase pathway signals for cytokine‐induced mRNA stabilization via MAP kinase‐activated protein kinase 2 and an AU‐rich region‐targeted mechanism , 1999, The EMBO journal.

[45]  J. Donadio.  Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. , 1991, Mayo Clinic proceedings.

[46]  R. Epand,et al.  Acyl chain dependence of diacylglycerol activation of protein kinase C activity in vitro. , 1996, Biochemical and biophysical research communications.

[47]  W. Wahli,et al.  PPARs: transcriptional effectors of fatty acids and their derivatives , 2002, Cellular and Molecular Life Sciences CMLS.

[48]  J. Pestka,et al.  Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  B. Angelin,et al.  Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. , 1994, Clinical nephrology.

[50]  John E. Linz,et al.  Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma. , 1994, Toxicology and applied pharmacology.

[51]  J. Pestka,et al.  Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. , 2000, Toxicology and applied pharmacology.

[52]  T. Hamazaki,et al.  EICOSAPENTAENOIC ACID AND IgA NEPHROPATHY , 1984, The Lancet.

[53]  J. Pestka,et al.  Immunomodulation by fungal toxins. , 2000, Journal of toxicology and environmental health. Part B, Critical reviews.

[54]  E. Shacter,et al.  Regulation of Macrophage Cytokine Production by Prostaglandin E2 , 1997, The Journal of Biological Chemistry.

[55]  J. Pestka,et al.  Superinduction of IL-2 gene expression by vomitoxin (deoxynivalenol) involves increased mRNA stability. , 1997, Toxicology and applied pharmacology.

[56]  S. Meydani,et al.  n-3 Polyunsaturated fatty acids and immune function , 1998, Proceedings of the Nutrition Society.

[57]  B. Goldin,et al.  Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. , 1991, The Journal of nutrition.

[58]  S. Helton,et al.  Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. , 1999, The Journal of surgical research.

[59]  J. Pestka,et al.  Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol). , 1999, Journal of toxicology and environmental health. Part A.

[60]  P. Calder,et al.  Inhibition of lymphocyte protein kinase C by unsaturated fatty acids. , 1993, Biochemical and biophysical research communications.

[61]  R. Thieringer,et al.  Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo , 2000, The Journal of Immunology.

[62]  J. Pestka,et al.  Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol) in vitro and in vivo. , 2003, Toxicology and applied pharmacology.

[63]  J. Pestka,et al.  Modulation of IL-1β, IL-6 and TNF-α secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line , 1998 .

[64]  A. Husband,et al.  The role of interleukin-6 in mucosal IgA antibody responses in vivo. , 1994, Science.

[65]  Y. Nishizuka.  Protein kinase C and lipid signaling for sustained cellular responses , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  A. Hichami,et al.  Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. , 2001, Journal of lipid research.

[67]  S. Wong,et al.  Superinduction of TNF-alpha and IL-6 in macrophages by vomitoxin (deoxynivalenol) modulated by mRNA stabilization. , 2001, Toxicology.

[68]  J. T. Wooten,et al.  Improved survival of heterotopic cardiac allografts in rats with dietary n-3 polyunsaturated fatty acids. , 1990, Transplantation.

[69]  P. Fraker,et al.  Endotoxin potentiation of trichothecene-induced lymphocyte apoptosis is mediated by up-regulation of glucocorticoids. , 2002, Toxicology and applied pharmacology.

[70]  E. Schiffrin,et al.  Docosahexaenoic Acid, a Peroxisome Proliferator–Activated Receptor-&agr; Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein Kinase , 2000, Hypertension.

[71]  J. Venkatraman,et al.  Effects of Dietary ω-3 and ω-6 Lipids and Vitamin E on Serum Cytokines, Lipid Mediators and Anti-DNA Antibodies in a Mouse Model for Rheumatoid Arthritis , 1999 .

[72]  J. Pestka,et al.  Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[73]  A. Hichami,et al.  Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells , 2002, Molecular and Cellular Biochemistry.

[74]  C. Jolly,et al.  Maintenance of NF-κB Activation in T-Lymphocytes and a Naive T-Cell Population in Autoimmune-Prone (NZB/NZW)F1 Mice by Feeding a Food-Restricted Diet Enriched with n-3 Fatty Acids , 2001 .

[75]  J. Pestka,et al.  Role of macrophages in elevated IgA and IL-6 production by Peyer's patch cultures following acute oral vomitoxin exposure. , 1998, Toxicology and applied pharmacology.

[76]  T. Leff,et al.  c-Jun N-Terminal Kinase Phosphorylates Peroxisome Proliferator-Activated Receptor-γ1 and Negatively Regulates Its Transcriptional Activity. , 1999, Endocrinology.

[77]  J. Pestka,et al.  In vitro effects of vomitoxin (deoxynivalenol) on T-cell interleukin production and IgA secretion. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.